Hannover House, Inc. (HHSE: OTC Pink Current) | Mother

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Hannover House, Inc. (HHSE: OTC Pink Current) | Mother Goose leads active Cannes Market for Hannover House

As a first-time exhibitor at the Cannes Film Festival and Marche du Film, Hannover House, Inc. (OTC: HHSE), closed deals for over $6.2-million in sales, pre-sales and co-productions, the company reported.  The upcoming fantasy adventure, "Mother Goose: Journey to Utopia" was by far the company's most active title, with additional sales and offers received for "The Legend of Belle Starr," the new acquisition of "Black-Eyed Dog," and from a wide range of territorial licenses received for a listing of ten catalog titles from Hannover House.

 

Territorial sales were made with France, Italy, Spain and the United Kingdom, with additional offers and opportunities being contemplated for Japan, South Korea, Russia, China and Australia-New Zealand. Co-production funding commitments and incentives have been accepted for production expenditures in Louisiana and the Republic of Ireland. Potential equity investments have been offered, but not yet accepted by Hannover House, from media investors in Dubai and China. Additionally, major bank lenders specializing in the monetization of international pre-sales and "gap" funding have approached the company about banking the "Mother Goose" project.

 

"The successful results already generated at Cannes are very exciting for the company and our shareholders," said Fred Shefte, President of Hannover House. "To generate close to double our annual revenues in one week here demonstrates the viability of our parallel path approach to the world media market for independent films. As we continue to build our core business in the lower-budgeted realm of direct-to-video releases for the U.S. market, the addition of major theatrical locomotives to drive our schedule is clearly working. There are major revenues to be achieved with these high-profile titles, and the international markets can in many cases exceed our U.S. results," he concluded.

 

In addition to generating sales on the Hannover House and Medallion properties, some exciting acquisition activities for the U.S. operations were also initiated and completed at Cannes. Last week, Hannover House closed the first major acquisition deal of the market with the North American pre-sale agreement for "Within Screaming Distance." The $5-million dollar thriller was written by legendary writer Joseph Stefano ("Psycho", "Outer Limits"), and chronicles the night of the Sharon Tate murders by the Charles Manson Family. Seven additional titles have also been acquired for the company's direct-to-video activities.

 

Newly completed production, "Black-Eyed Dog" from director Erica Dunton has generated strong international interest - in part due to lead star Mackenzie Foy's current star role in the Christopher Nolan epic "Interstellar," opening worldwide this November by Paramount. Industry trade publication, The Business of Film, selected "Black-Eyed Dog" as its featured page one title for the Day Five Cannes Market edition, due to buyer buzz about young actress Mackenzie Foy.

 

Hannover House was formed in 1993 as a book publisher. DVDs were added as a product line in 2003, and by 2004, the company began dabbling in limited release theatrical titles such as ?Off The Lip?, ?Hounddog? and ?War Eagle, Arkansas? to enhance the films? profile for the DVD and Video-On-Demand markets.  In 2010, Hannover House licensed the Joel Schumacher thriller, ?Twelve? at the Sundance Film Festival, for a sizable advance to production entity, Gaumont, of $1.75-million.  The film was released that summer to 220 theatres, and became a significant DVD and Blu-Ray hit through a distribution pact with 20th Century Fox Home Entertainment.  However, since 2010, the company has not secured distribution rights to any major theatrical titles. The formation of Medallion and the capital access that this venture provides through markets such as Cannes, is expected to provide Hannover House with major releases to drive its release slate.

 

SAFE HARBOR STATEMENT

This press release may contain certain forward-looking statements within the meaning of Sections 27A & 21E of the amended Securities and Exchange Acts of 1933-34, which are intended to be covered by the safe harbors created thereby. Although the company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, there can be no assurance that these statements included in this press release will prove accurate.

 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 2

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 7

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 2

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 8

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 6

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 2

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 4

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 4

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 3

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

AstroTurf Corporation Expands Its Reach with New Acquisition

Updated Category News Views 554

AstroTurf Corporation Expands Its Portfolio AstroTurf Corporation, a prominent player in the synthetic sports surfacing industry, has recently announced its acquisition of Coast to Coast Turf, a highly regarded artificial turf installer based out of Seattle. This strategic move aims to expand AstroTurf's influence and operational capacity. Leadership Transition and...

Continue Reading
Understanding Short Interest Dynamics for Everest Group

Updated Category News Views 127

Analyzing Short Interest Trends in Everest Group Everest Group recently reported an increase in its short percent of float, which has risen to an impressive 28.07%. Currently, there are approximately 799 thousand shares sold short, accounting for 2.92% of the total shares available for trading. Given the current trading volume, it would take traders an average of 1.73...

Continue Reading
Long-term Partnership between Flutter Entertainment and Aviator

Updated Category News Views 172

Flutter Entertainment and Aviator Forge a Strategic Alliance Flutter Entertainment, a renowned entity in the gaming industry, has recently announced a significant collaboration with Aviator LLC. This partnership promises a dynamic future for both companies as they look to leverage each other's strengths. Details of the Partnership The agreement between Flutter and Aviator...

Continue Reading
Certara's Upcoming Participation in Investor Conferences

Updated Category News Views 78

Certara's Upcoming Participation in Investor Conferences Certara, Inc. (Nasdaq: CERT), a worldwide leader in model-informed drug development, has announced its involvement in several key investor conferences. These events represent important opportunities for the company to connect with both current and potential investors, highlighting its dedication to advancing drug...

Continue Reading
Salazar's Dual Threat: High-Grade Gold & Vast Copper

Updated Category News Views 8

Ecuador's Hidden Treasure: Salazar Resources Sparks Interest You have to hand it to Salazar Resources Limited; they're sitting on some rather intriguing turf. Right smack in Ecuador's copper-gold belt, they've unearthed two stellar mineral prospects on their Tarqui concession—kind of like hitting a double jackpot. We're talking a gold-silver vein system flashing gaudy...

Continue Reading